At1g06710 Antibody

What is the At1g06710 gene and its encoded protein MTSF1?

At1g06710 is a gene model identifier in Arabidopsis thaliana that encodes MTSF1 (MITOCHONDRIAL STABILITY FACTOR 1), a PPR (Pentatricopeptide Repeat) containing protein belonging to the P subfamily. This protein plays a crucial role in mitochondrial RNA metabolism, specifically in the processing and stability of nad4 transcripts within plant mitochondria. MTSF1 is part of a larger family of PPR proteins that function as sequence-specific RNA-binding proteins involved in post-transcriptional processes in organelles. The gene has been characterized through functional genomics approaches and has been confirmed to have mitochondrial localization through experimental validation .

How is At1g06710/MTSF1 protein localized within plant cells?

According to systematic subcellular localization studies, MTSF1 (At1g06710) demonstrates clear mitochondrial localization. In experimental studies using fluorescent protein tagging, researchers have confirmed its mitochondrial targeting, which is consistent with its functional role in mitochondrial RNA processing. The protein contains a predicted mitochondrial targeting sequence and experimental validation by Haïli et al. confirms this localization. This mitochondrial localization is critical for its function in processing and stabilizing the nad4 transcript, which encodes a subunit of mitochondrial complex I .

How should researchers validate the specificity of At1g06710/MTSF1 antibodies?

Validation of At1g06710/MTSF1 antibodies requires a multi-faceted approach to ensure specificity. Begin with Western blot analysis using both wild-type and knockout/knockdown plant tissues to confirm the presence of bands at the expected molecular weight (~41 kDa) in wild-type samples and their absence in knockout samples. This approach is essential given the documented issues with antibody cross-reactivity in plant research. As demonstrated in comparable antibody validation studies, different commercial antibodies targeting the same protein can produce significantly different banding patterns, highlighting the importance of rigorous validation protocols .

Additionally, researchers should perform immunoprecipitation followed by mass spectrometry to confirm that the antibody pulls down the target protein. Immunohistochemistry should be conducted with appropriate controls, including pre-immune serum and antigen pre-absorption controls. For definitive validation, expressing the target protein with an orthogonal tag (such as GFP or FLAG) and demonstrating co-localization or co-immunoprecipitation with the antibody provides strong evidence of specificity .

What are the optimal storage and handling conditions for At1g06710/MTSF1 antibodies?

For optimal performance and longevity of At1g06710/MTSF1 antibodies, proper storage and handling are essential. According to product information, these antibodies are typically supplied in lyophilized form and should be stored at -20°C to -70°C upon receipt. After reconstitution, aliquot the antibody to avoid repeated freeze-thaw cycles, which can significantly degrade antibody performance. The antibody remains stable for approximately 12 months from the date of receipt when stored properly at -20°C to -70°C, and for about 6 months after reconstitution when stored at the same temperature range .

For shipping and short-term storage, the antibody can be kept at 4°C, but should be transferred to recommended storage conditions immediately upon receipt. When working with the antibody, always use proper sterile technique and keep the working solution on ice. Avoid multiple freeze-thaw cycles by preparing single-use aliquots, as each cycle can reduce antibody activity by approximately 10-20% .

What control samples should be used when performing experiments with At1g06710 antibodies?

When conducting experiments with At1g06710 antibodies, rigorous controls are essential for accurate data interpretation. Primary controls should include a negative control omitting the primary antibody to assess background staining levels, as illustrated in comparable immunohistochemistry studies where minimal background staining was observed in the absence of primary antibody . Additionally, researchers should use gene knockout or knockdown plant materials (e.g., T-DNA insertion lines, CRISPR-edited lines, or RNAi lines) as negative controls to confirm antibody specificity.

Positive controls should include tissues known to express high levels of MTSF1, such as rapidly growing plant tissues with high mitochondrial activity. For quantitative experiments, researchers should include calibration standards with known quantities of recombinant MTSF1 protein. Peptide competition assays, where the antibody is pre-incubated with the immunizing peptide before application to the sample, can also verify binding specificity. These comprehensive controls will help distinguish between specific signal and non-specific background, which is crucial for accurately interpreting experimental results .

How should researchers design Western blotting protocols for optimal At1g06710/MTSF1 detection?

For optimal Western blotting detection of At1g06710/MTSF1, researchers should employ a carefully optimized protocol tailored to this plant mitochondrial protein. Begin with efficient extraction by using a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, supplemented with protease inhibitors and 10 mM DTT to protect against oxidation of plant proteins. When preparing samples, maintain cold temperatures throughout processing to prevent proteolytic degradation, and enrich for mitochondrial fractions to increase detection sensitivity if necessary .

For gel electrophoresis, use 10-12% SDS-PAGE gels for optimal resolution around the expected molecular weight (41 kDa) of MTSF1. During protein transfer, employ PVDF membranes rather than nitrocellulose for their superior protein retention and signal-to-noise ratio with plant proteins. For blocking, 5% non-fat dry milk in TBST is typically effective, but empirically test BSA as an alternative if high background persists. Optimize primary antibody concentration through titration experiments (typically starting at 1:1000 dilution) and incubate overnight at 4°C to maximize specific binding. For detection, HRP-conjugated secondary antibodies with enhanced chemiluminescence provide good sensitivity, but consider fluorescent secondary antibodies for quantitative analyses requiring a broader linear dynamic range .

What approaches should be used for immunolocalization of At1g06710/MTSF1 in plant tissues?

For effective immunolocalization of At1g06710/MTSF1 in plant tissues, researchers should employ a comprehensive approach that preserves both tissue morphology and protein antigenicity. Begin with fixation using 4% paraformaldehyde in phosphate buffer, which maintains cellular ultrastructure while preserving antibody epitopes. For Arabidopsis, use young tissues with active mitochondria, as these will have higher MTSF1 expression levels. Perform antigen retrieval using citrate buffer (pH 6.0) with gentle heating to expose epitopes that may be masked during fixation, which is particularly important for mitochondrial proteins .

For tissue permeabilization, use a gentle approach with 0.1% Triton X-100 for 15-20 minutes to allow antibody penetration while maintaining mitochondrial integrity. When applying primary antibody, dilute appropriately (typically 1:50 to 1:200) and incubate in a humid chamber overnight at 4°C to maximize specific binding while minimizing background. For detection, fluorescently-labeled secondary antibodies are preferable as they allow co-localization with mitochondrial markers. Counterstain with MitoTracker or antibodies against known mitochondrial proteins to confirm subcellular localization. Finally, analyze using confocal microscopy with appropriate filter sets to visualize the specific localization pattern of MTSF1 within mitochondria across different plant tissues and cell types .

How can researchers effectively use At1g06710/MTSF1 antibodies in co-immunoprecipitation experiments?

For effective co-immunoprecipitation (co-IP) experiments using At1g06710/MTSF1 antibodies, researchers should implement a protocol optimized for plant mitochondrial protein complexes. Begin with gentle extraction using a buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, supplemented with protease inhibitors and RNase inhibitors if RNA-protein interactions are being investigated. Pre-clear the lysate with Protein A/G beads to reduce non-specific binding, which is particularly important when working with plant extracts that contain abundant polyphenolic compounds and polysaccharides that may cause non-specific interactions .

Pre-bind the At1g06710/MTSF1 antibody to Protein A/G magnetic beads (typically 2-5 μg antibody per experiment) for 1 hour at room temperature before adding to the pre-cleared lysate. For the immunoprecipitation step, incubate the antibody-bead complex with the lysate overnight at 4°C with gentle rotation to maintain native protein complexes. Include appropriate controls such as IgG from the same species as the primary antibody and input samples. For elution, use a gentle approach with a glycine buffer (pH 2.5) followed by immediate neutralization to preserve complex integrity. Analyze immunoprecipitated complexes by Western blotting for known interaction partners or by mass spectrometry for unbiased identification of novel interaction partners .

How does the function of At1g06710/MTSF1 compare to other PPR proteins in plant organelles?

At1g06710/MTSF1 belongs to the P subfamily of PPR proteins and functions specifically in processing and stabilizing the nad4 transcript in mitochondria. Compared to other PPR proteins, MTSF1 shares the characteristic RNA-binding function but differs in its specific RNA targets and molecular mechanisms. Unlike PLS-E and PLS-E-DYW subfamily members that primarily function in RNA editing, MTSF1 as a P-type PPR protein primarily mediates RNA stability and processing without editing activity. The specific RNA recognition patterns of MTSF1 are determined by the amino acid combinations at key positions in its PPR motifs, which differ from those in other PPR proteins .

In contrast to chloroplast-targeted PPR proteins like CLB19 that edit chloroplast transcripts (rpoA and clpP), or dual-targeted PPR proteins that coordinate gene expression between organelles, MTSF1 demonstrates exclusive mitochondrial localization and function. This specialization highlights the evolutionary diversification of PPR proteins to perform distinct molecular functions in different organellar compartments. The systematic study of subcellular localization demonstrates that while some PPR proteins show dual targeting or ambiguous localization patterns, MTSF1 displays clear mitochondrial specificity, underscoring its dedicated role in mitochondrial RNA metabolism .

What are common troubleshooting strategies for non-specific binding with At1g06710 antibodies?

When encountering non-specific binding with At1g06710 antibodies, implement a systematic troubleshooting approach to improve specificity. Begin by optimizing blocking conditions, testing different blocking agents such as 5% BSA, 5% non-fat dry milk, or commercial blocking solutions specifically designed for plant tissues. Increase blocking time to 2 hours at room temperature or overnight at 4°C to reduce background. Consider performing a pre-adsorption step where the antibody is incubated with proteins extracted from knockout plant material to remove antibodies that bind to non-target epitopes .

For Western blotting applications, increase the stringency of washing steps by using higher concentrations of Tween-20 (0.05-0.1%) in TBST and extending washing times. Additionally, optimize salt concentration in washing buffers (150-500 mM NaCl) to disrupt non-specific ionic interactions. If multiple bands persist, consider using gradient gels for better resolution and transferring to PVDF membranes which can provide better signal-to-noise ratios than nitrocellulose for some plant proteins. For immunohistochemistry, include additional permeabilization steps and optimize antibody dilution through careful titration experiments. As demonstrated in comparable antibody validation studies, different antibodies against the same target can produce dramatically different results, emphasizing the importance of thorough validation for each specific application .

How can researchers investigate the RNA-binding properties of At1g06710/MTSF1 using immunoprecipitation approaches?

To investigate the RNA-binding properties of At1g06710/MTSF1, researchers can employ RNA immunoprecipitation (RIP) combined with high-throughput sequencing (RIP-seq). Begin by crosslinking RNA-protein complexes in plant tissue using 1% formaldehyde for 10 minutes, followed by quenching with glycine. Extract proteins using a specialized RIP buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 0.5% NP-40, supplemented with protease inhibitors, RNase inhibitors, and 1 mM DTT. Sonicate the lysate gently to shear DNA without disrupting RNA-protein complexes, then pre-clear with Protein A/G beads .

Immunoprecipitate MTSF1-RNA complexes using validated At1g06710 antibodies pre-bound to Protein A/G beads, incubating overnight at 4°C with gentle rotation. Include IgG control immunoprecipitations and input samples for normalization. After extensive washing to remove non-specific interactions, reverse crosslinking by heating at 65°C for 2 hours in the presence of proteinase K. Extract RNA using TRIzol reagent followed by DNase treatment to remove genomic DNA contamination. The purified RNA can then be analyzed by RT-qPCR for specific target transcripts (particularly nad4) or by high-throughput sequencing to identify the complete spectrum of RNA molecules bound by MTSF1 .

What techniques can be used to study the interaction between At1g06710/MTSF1 and mitochondrial transcripts?

To study the specific interactions between At1g06710/MTSF1 and mitochondrial transcripts, researchers can employ multiple complementary techniques. Begin with electrophoretic mobility shift assays (EMSA) using recombinant MTSF1 protein and synthetic RNA oligonucleotides derived from predicted binding sites in nad4 and other potential target transcripts. This approach allows for direct visualization of protein-RNA complexes and can be used to determine binding affinities and sequence specificities. For a more detailed analysis of binding sites, perform RNA footprinting assays using RNases or chemical probes to identify nucleotides protected by MTSF1 binding .

For in vivo validation, implement RNA immunoprecipitation followed by RT-qPCR to quantify enrichment of specific transcripts. This can be complemented with CLIP-seq (Crosslinking Immunoprecipitation-sequencing), which combines UV crosslinking of RNA-protein complexes with immunoprecipitation and high-throughput sequencing to map binding sites at nucleotide resolution. To understand the functional consequences of these interactions, analyze nad4 transcript stability and processing in mtsf1 mutant plants compared to wild-type using northern blotting and circular RT-PCR to identify transcript ends. These approaches collectively provide a comprehensive understanding of how MTSF1 recognizes and influences its RNA targets in mitochondria .

How should researchers interpret discrepancies in At1g06710/MTSF1 antibody staining patterns across different experimental conditions?

When encountering discrepancies in At1g06710/MTSF1 antibody staining patterns across different experimental conditions, researchers should conduct a systematic analysis of potential variables affecting antibody performance. First, examine fixation methods, as overfixation can mask epitopes while underfixation may not adequately preserve cellular structures. Compare results across different fixatives (paraformaldehyde, glutaraldehyde, or combinations) and fixation times to determine optimal conditions for MTSF1 detection. Second, evaluate tissue processing variables, as embedding media, sectioning thickness, and antigen retrieval methods can significantly impact antibody accessibility to epitopes .

Third, consider developmental and physiological variables, as MTSF1 expression and localization may change during plant development or in response to environmental conditions. Fourth, assess antibody variables by comparing different lots of the same antibody and different commercial antibodies against the same target. As demonstrated in comparable studies with AT1R antibodies, different antibodies against the same protein can produce dramatically different staining patterns, making validation crucial. Finally, use genetic controls (knockout/knockdown plants) and complementary techniques (fluorescent protein tagging, in situ hybridization) to distinguish between true biological variation and technical artifacts. This comprehensive approach will help determine whether staining discrepancies represent genuine biological phenomena or technical limitations .

What considerations should be made when designing experiments to study At1g06710/MTSF1 function in different plant species?

When designing experiments to study At1g06710/MTSF1 function across different plant species, researchers must address several critical considerations. First, conduct comprehensive bioinformatic analyses to identify true orthologs of Arabidopsis MTSF1 in target species, using both sequence similarity and synteny information to confirm orthology. Be aware that PPR proteins have undergone rapid evolution and expansion in different plant lineages, making ortholog identification challenging. Second, validate antibody cross-reactivity with the species of interest using Western blotting and immunoprecipitation followed by mass spectrometry, as antibody epitopes may not be conserved across diverse plant species .

According to product information, the PHY3994S antibody has confirmed cross-reactivity with Arabidopsis thaliana, Brassica napus, and Brassica rapa, while the PHY3997S antibody is specific to Arabidopsis thaliana only. Third, optimize experimental protocols for each species, accounting for differences in tissue composition, cell wall structure, and secondary metabolites that may affect protein extraction efficiency and antibody accessibility. Fourth, develop species-specific genetic resources, such as CRISPR-edited lines or RNAi constructs, to functionally validate MTSF1 roles. Finally, consider evolutionary context when interpreting results, as MTSF1 function may have diverged in species with different mitochondrial genome organizations or RNA processing pathways .

What complementary techniques should be used alongside At1g06710 antibody-based methods to comprehensively study MTSF1 function?

To comprehensively study MTSF1 function, researchers should implement multiple complementary techniques alongside antibody-based methods. Genetic approaches using CRISPR-Cas9 gene editing or T-DNA insertion lines provide essential loss-of-function data, while complementation assays with fluorescently-tagged MTSF1 variants can validate subcellular localization and rescue mutant phenotypes. Transcriptomic analyses using RNA-seq can reveal global changes in gene expression in mtsf1 mutants, particularly focusing on mitochondrial transcript levels and processing patterns. Proteomics approaches, including quantitative mass spectrometry, can identify changes in the mitochondrial proteome resulting from MTSF1 dysfunction .

For detailed mechanistic studies, in vitro RNA binding assays such as EMSA and RNA footprinting can define the molecular basis of MTSF1-RNA interactions. Structural biology approaches, including cryo-EM or X-ray crystallography of MTSF1-RNA complexes, though challenging, would provide invaluable insights into the molecular recognition mechanism. Physiological phenotyping, including measurements of mitochondrial respiration, ATP production, and reactive oxygen species levels, can connect molecular functions to cellular physiology. Finally, evolutionary analyses comparing MTSF1 sequences and functions across plant species can reveal conserved and divergent aspects of PPR protein evolution. This multi-faceted approach provides a comprehensive understanding of MTSF1 function beyond what can be achieved with antibody-based methods alone .

How does our understanding of At1g06710/MTSF1 contribute to the broader field of plant mitochondrial gene expression?

At1g06710/MTSF1 represents a critical component in our understanding of post-transcriptional regulation in plant mitochondria. As a P-type PPR protein specifically involved in nad4 transcript processing and stability, MTSF1 exemplifies how plants have evolved sophisticated RNA-binding proteins to regulate organellar gene expression post-transcriptionally. This is particularly significant because plant mitochondrial genomes have unique features compared to their animal counterparts, including complex RNA processing requirements and extensive RNA editing. The functional characterization of MTSF1 has contributed to our understanding of how mitochondrial gene expression is fine-tuned at the RNA level, revealing mechanisms that ensure proper stoichiometry of respiratory complex components .

Furthermore, MTSF1 research highlights the importance of nuclear-encoded factors in regulating mitochondrial function, demonstrating the intricate coordination between nuclear and mitochondrial genomes. The study of MTSF1 and other PPR proteins has expanded our knowledge of how sequence-specific RNA recognition occurs and how these interactions influence RNA fate. This research area connects to broader questions in plant biology, including energy metabolism, stress responses, and adaptive evolution, as mitochondrial function is central to plant performance under diverse environmental conditions .

What emerging technologies might enhance our ability to study At1g06710/MTSF1 and related PPR proteins?

Emerging technologies offer exciting possibilities for advancing our understanding of At1g06710/MTSF1 and related PPR proteins. CRISPR-based technologies beyond gene knockout, such as CRISPRi for transcriptional repression or CRISPRa for activation, could enable more nuanced manipulation of MTSF1 expression. Base editing and prime editing techniques could introduce specific point mutations to test the functional importance of individual amino acids in RNA recognition. Single-cell transcriptomics and proteomics approaches could reveal cell type-specific functions of MTSF1 that might be masked in whole-tissue analyses .